About

About BillionToOne - NorthStar We’re a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront of everything we do. We are currently applying our proprietary technology to non-invasive prenatal screening and liquid biopsy. The Northstar Select™ provides a prioritized list of mutations that are present in the tumor. The types of mutations detected include deletions, insertions, and point-mutations. At the same time, it helps rule-in / rule-out relationship of mutations to drugs and provides an accurate read on the covered genes. The Northstar Response™ provides longitudinal determination of cancer burden via methylation assessment.